Menu

喜保宁2022价格,多少钱一盒?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

On May 29, 2019, the National Health Commission, the Ministry of Industry and Information Technology, and the State Food and Drug Administration jointly released the "Second Batch of Clinically Urgent Overseas New Drug List", which included Denmark's Lundbeck Company's (vigabatrin, SABRILR). The indications are: infantile spasms (IS) in infants aged 1 month to 2 years old; together with other therapies, it is used to treat refractory complex partial seizure epilepsy (CPS) in adults and children aged 10 years and above. The reason for the urgent clinical need is "children's medicine and rare disease medicine", but unfortunately, the drug is not currently on the market in China. So, how much does a box of Vigabatrin 2022 cost?

Vigabatrin 2022 price

Vigabatrin is a gamma-aminobutyric acid transaminase inhibitor. As early as the 1990s in Europe, Vigabatrin was used as one of the therapeutic drugs for IS, but it is not currently on the market in China. The currently known versions and prices of Vigabatrin are as follows:

The Turkish version of French Sanofi Vigabatrin (vigabatrin) is available in 500 mg x 100 capsules, priced at 750$.

The Hong Kong version of France's Sanofi Vigabatrin (vigabatrin) is 500mg x 100 capsules and the price is 1850$.

France's Sanofi Vigabatrin (vigabatrin) Taiwan version has a specification of 500mgx100 capsules and a price of 1100$.

Vigabatrin price per month

There are differences in the usage of Vigabatrin between adults and children. Here we mainly introduce the dosage for children. If the child is between 3 and 9 years old, the recommended dose of the drug is 1g per day, taken in 2 times; for older children, 2g per day, taken in 2 times. It can be seen that if you are an older child, you need to use 4 tablets of Vigabatrin a day and 120 tablets a month. If you are a younger child, you need 2 tablets a day and 60 tablets a month. If you use the above version of the drug, it will cost 750~1100$, which is very cost-effective.

Recommended related articles:

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。